lapachol has been researched along with Lung Diseases in 1 studies
lapachol : A hydroxy-1,4-naphthoquinone that is 1,4-naphthoquinone substituted by hydroxy and 3-methylbut-2-en-1-yl groups at positions 2 and 3, respectively. It is a natural compound that exhibits antibacterial and anticancer properties, first isolated in 1882 from the bark of Tabebuia avellanedae.
Lung Diseases: Pathological processes involving any part of the LUNG.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Riça, IG | 1 |
| Netto, CD | 1 |
| Rennó, MN | 1 |
| Abreu, PA | 1 |
| Costa, PRR | 1 |
| da Silva, AJM | 1 |
| Cavalcante, MCM | 1 |
1 other study available for lapachol and Lung Diseases
| Article | Year |
|---|---|
Anti-inflammatory properties of pterocarpanquinone LQB-118 in mice.
Topics: Animals; Anti-Inflammatory Agents; Disease Models, Animal; Hydrogen Bonding; Inflammation; Lung Dise | 2016 |